205 related articles for article (PubMed ID: 7913908)
21. Effects of two peroxisome proliferators (ciprofibrate and fenofibrate) on peroxisomal membrane proteins and dihydroxyacetone-phosphate acyl-transferase activity in rat liver.
Causeret C; Bentejac M; Clemencet MC; Bugaut M
Cell Mol Biol (Noisy-le-grand); 1993 Feb; 39(1):65-80. PubMed ID: 8467241
[TBL] [Abstract][Full Text] [Related]
22. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.
Klucis E; Crane DI; Hughes JL; Poulos A; Masters CJ
Biochim Biophys Acta; 1991 Jul; 1074(2):294-301. PubMed ID: 1676600
[TBL] [Abstract][Full Text] [Related]
23. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
24. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
26. [Peroxisomal beta-oxidation].
Mannaerts GP; Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
[TBL] [Abstract][Full Text] [Related]
27. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression.
Zangar RC; Woodcroft KJ; Novak RF
Toxicol Appl Pharmacol; 1996 Nov; 141(1):110-6. PubMed ID: 8917682
[TBL] [Abstract][Full Text] [Related]
29. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
Reddy JK
Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment.
Hollinshead M; Meijer J
Eur J Cell Biol; 1988 Aug; 46(3):394-402. PubMed ID: 3181162
[TBL] [Abstract][Full Text] [Related]
31. Proliferation of myocardial peroxisomes caused by several agents and conditions.
Zipper J
J Mol Cell Cardiol; 1997 Jan; 29(1):149-61. PubMed ID: 9040030
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
Richert L; Price S; Chesne C; Maita K; Carmichael N
Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
[TBL] [Abstract][Full Text] [Related]
33. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
34. Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.
Borges T; Glauert HP; Robertson LW
Toxicol Appl Pharmacol; 1993 Jan; 118(1):8-15. PubMed ID: 8430427
[TBL] [Abstract][Full Text] [Related]
35. Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro.
Bars RG; Bell DR; Elcombe CR
Biochem Pharmacol; 1993 May; 45(10):2045-53. PubMed ID: 7685601
[TBL] [Abstract][Full Text] [Related]
36. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1994 Jun; 126(2):233-9. PubMed ID: 8209376
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical localization of catalase and heat-labile enoyl-CoA hydratase in the livers of normal and peroxisome proliferator-treated rats.
Bendayan M; Reddy JK
Lab Invest; 1982 Oct; 47(4):364-9. PubMed ID: 7120922
[TBL] [Abstract][Full Text] [Related]
38. Application of automatic image analysis for quantitative morphological studies of peroxisomes in rat liver in conjunction with cytochemical staining with 3-3'-diaminobenzidine and immunocytochemistry.
Beier K; Fahimi HD
Microsc Res Tech; 1992 Jun; 21(4):271-82. PubMed ID: 1379091
[TBL] [Abstract][Full Text] [Related]
39. Using laser scanning cytometry to measure PPAR-mediated peroxisome proliferation and beta oxidation.
Pruimboom-Brees IM; Brees DJ; Shen AC; Keener M; Francone O; Amacher DE; Loy JK; Kerlin RL
Toxicol Pathol; 2005; 33(1):86-91. PubMed ID: 15805059
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
